CDC, PEPFAR, and BD Partner
to Transform Healthcare in Africa
Today, April 20th, in Washington DC, Dr. Shannon Hader, Dr. John Nkengasong and CDC staff from around the world will join forces with the President’s Emergency Program for AIDS Relief (PEPFAR) , and Becton Dickinson and Company (BD) to release the results of an innovative public-private partnership that is transforming healthcare in four African countries where the burden of HIV and TB are among the greatest in the world. Under the leadership of Ministries of Health in these countries, this unique partnership, dubbed Labs for Life , was created to strengthen fragile laboratory systems in Kenya, Mozambique, Ethiopia, and Uganda, thereby allowing these countries to effectively prevent, identify, and respond to both today’s healthcare challenges and tomorrow’s public health threats. The first phase of the partnership, from 2007 - 2012, is a powerful example of DGHT’s commitment and investment in laboratory expertise worldwide and is a model for future programs in other high burden countries. This partnership provides evidence that when done well, public-private partnerships can provide innovative solutions to pressing global health challenges.
Presenting at today’s event will be the U.S. Global AIDS Coordinator, Ambassador Deborah Birx, MD, Director of CDC’s Division of Global HIV & TB (DGHT ) Shannon Hader, MD, MPH, and CEO of BD Mr. Vincent Forlenza. Also, in attendance will be the Chief of DGHT’s International Laboratory Branch , John Nkengasong, PhD. Details of the partnership, including country-specific case studies, are featured in this month’s Journal of Infectious Diseases.
Resources
To learn more about this innovative public private partnership to transform laboratory systems throughout Africa, CDC’s Division of Global HIV and TB offers the following resources:
Factsheet summarizing the successes of the Labs for Life public-private partnership
Infographic illustrating the impact of the partnership throughout Africa
Feature article and photo gallery highlighting the on-the-ground impact of Labs for Life
Journal of Infectious Disease article on findings from the 5-year public-private partnership
No hay comentarios:
Publicar un comentario